Literature DB >> 34125202

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review.

David Stevens1,2, Stephanie L Harrison1,2, Ruwanthi Kolamunnage-Dona3, Gregory Y H Lip1,2,4, Deirdre A Lane1,2,4.   

Abstract

The 2020 European Society of Cardiology guidelines endorse the Atrial Fibrillation Better Care (ABC) pathway as a structured approach for the management of atrial fibrillation (AF), addressing three principal elements: 'A' - avoid stroke (with oral anticoagulation), 'B' - patient-focused better symptom management, and 'C' - cardiovascular and comorbidity risk factor reduction and management. This review summarizes the definitions used for the ABC criteria in different studies and the impact of adherence/non-adherence on clinical outcomes, from 12 studies on seven different cohorts. All studies consistently showed statistically significant reductions in the risk of stroke, myocardial infarction, and mortality among those with ABC pathway adherent treatment. The ABC pathway provides a simple decision-making framework to enable consistent equitable care from clinicians in primary and secondary/tertiary care. Further research examining the impact of ABC pathway implementation in prospective cohorts utilizing consistent inclusion criteria and definitions of 'A', 'B', and 'C' adherent care is warranted.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  ABC pathway; Atrial fibrillation; Integrated care; Management; Patients; Review

Year:  2021        PMID: 34125202     DOI: 10.1093/europace/euab092

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  5 in total

1.  Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry.

Authors:  María Asunción Esteve-Pastor; Martín Ruiz-Ortiz; Javier Muñiz; Inmaculada Roldán-Rabadán; Déborah Otero; Ángel Cequier; Vicente Bertomeu-Martínez; Lina Badimón; Manuel Anguita; Gregory Y H Lip; Francisco Marín
Journal:  Front Cardiovasc Med       Date:  2022-05-02

2.  Reaching Frail Elderly Patients to Optimize Diagnosis and Management of Atrial Fibrillation (REAFEL): A Feasibility Study of a Cross-Sectoral Shared-Care Model.

Authors:  Caroline Thorup Ladegaard; Carsten Bamberg; Mathias Aalling; Dorthea Marie Jensen; Nina Kamstrup-Larsen; Christoffer Valdorff Madsen; Sadaf Kamil; Henrik Gudbergsen; Thomas Saxild; Michaela Louise Schiøtz; Julie Grew; Luana Sandoval Castillo; Anne Frølich; Helena Domínguez
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

3.  Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.

Authors:  José Maria Farinha; Ian D Jones; Gregory Y H Lip
Journal:  Eur Heart J Suppl       Date:  2022-02-14       Impact factor: 1.803

4.  Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry.

Authors:  Agnieszka Kotalczyk; Yutao Guo; Maria Stefil; Yutang Wang; Gregory Y H Lip
Journal:  J Am Heart Assoc       Date:  2022-04-04       Impact factor: 6.106

5.  Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists.

Authors:  Vanessa Roldán; Lorena Martínez-Montesinos; Raquel López-Gálvez; Lucía García-Tomás; Gregory Y H Lip; José Miguel Rivera-Caravaca; Francisco Marín
Journal:  J Pers Med       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.